Mehta, A., Bowling, A., Gordon, E. R., Adeuyan, O., Lapolla, B. A., Gru, A., & Geskin, L. J. (2025). Concomitant Squamous Cell Carcinoma and Mycosis Fungoides Within the Same Lesion: A Case Report and Literature Review. The American Journal of Dermatopathology, 47(6), 472–476. https://doi.org/10.1097/dad.0000000000002975

Jain, S., Bai, X., Mallick, S., Kinghorn, B., May, B., Yao, A. G., Allen-Gipson, D., Zhang, X., Henick, B. S., Momen-Heravi, F., Carrot-Zhang, J., & Taylor, A. M. (2024). Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma. JCO Precision Oncology, 8. https://doi.org/10.1200/po.24.00223

Queen, D., Trager, M. H., Fan, W., Gordon, E. R., & Samie, F. H. (2024). Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ. Archives of Dermatological Research, 316(6). https://doi.org/10.1007/s00403-024-02906-4

Nadir, U., Yi, M. D., Koza, E., Shi, V. J., Dave, L., Hisham, F. I., Maisel-Campbell, A., Lin, K. A., Ibrahim, S. A., Kang, B. Y., Anvery, N., Dirr, M. A., Christensen, R. E., Riley, J. M., Kundu, R. V., Aylward, J. L., Bari, O., Bhatti, H., Bolotin, D., … Alam, M. (2024). Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study. Journal of the American Academy of Dermatology, 90(6), 1243–1245. https://doi.org/10.1016/j.jaad.2023.11.069

Morgado-Palacin, L., Brown, J. A., Martinez, T. F., Garcia-Pedrero, J. M., Forouhar, F., Quinn, S. A., Reglero, C., Vaughan, J., Heydary, Y. H., Donaldson, C., Rodriguez-Perales, S., Allonca, E., Granda-Diaz, R., Fernandez, A. F., Fraga, M. F., Kim, A. L., Santos-Juanes, J., Owens, D. M., Rodrigo, J. P., … Ferrando, A. A. (2023). The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-36713-8

Muthupalani, S., Annamalai, D., Feng, Y., Ganesan, S. M., Ge, Z., Whary, M. T., Nakagawa, H., Rustgi, A. K., Wang, T. C., & Fox, J. G. (2023). IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-39907-8

Connelly, C. F., Collins, N., Cimic, A., & Baskota, S. U. (2023). Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results. American Journal of Clinical Pathology, 160(5), 444–449. https://doi.org/10.1093/ajcp/aqad070

Park, S. J., Min, H. J., Yoon, C., Kim, S. H., Kim, J. H., & Lee, S. Y. (2023). Integrin β1 regulates the perineural invasion and radioresistance of oral squamous carcinoma cells by modulating cancer cell stemness. Cellular Signalling, 110, 110808. https://doi.org/10.1016/j.cellsig.2023.110808

Ko, K.-P., Huang, Y., Zhang, S., Zou, G., Kim, B., Zhang, J., Jun, S., Martin, C., Dunbar, K. J., Efe, G., Rustgi, A. K., Nakagawa, H., & Park, J.-I. (2023). Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion. Gastroenterology, 165(3), 613-628.e20. https://doi.org/10.1053/j.gastro.2023.05.030

Kinslow, C. J., Yu, J. B., DeStephano, D. M., Kachnic, L. A., Cheng, S. K., Neugut, A. I., & Horowitz, D. P. (2023). Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ. JAMA Surgery, 158(7), 769. https://doi.org/10.1001/jamasurg.2023.0262

Li, J., Momen‐Heravi, F., Wu, X., & He, K. (2022). Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Diseases, 29(5), 2012–2026. Portico. https://doi.org/10.1111/odi.14220

Zhang, Y., Black, K. E., Phung, T.-K. N., Thundivalappil, S. R., Lin, T., Wang, W., Xu, J., Zhang, C., Hariri, L. P., Lapey, A., Li, H., Lerou, P. H., Ai, X., Que, J., Park, J.-A., Hurley, B. P., & Mou, H. (2023). Human Airway Basal Cells Undergo Reversible Squamous Differentiation and Reshape Innate Immunity. American Journal of Respiratory Cell and Molecular Biology, 68(6), 664–678. https://doi.org/10.1165/rcmb.2022-0299oc

Monroy, D., Serrano, A., Galor, A., & Karp, C. L. (2023). Medical treatment for ocular surface squamous neoplasia. Eye, 37(5), 885–893. https://doi.org/10.1038/s41433-023-02434-x

Puram, S. V., Mints, M., Pal, A., Qi, Z., Reeb, A., Gelev, K., Barrett, T. F., Gerndt, S., Liu, P., Parikh, A. S., Ramadan, S., Law, T., Mroz, E. A., Rocco, J. W., Adkins, D., Thorstad, W. L., Gay, H. A., Ding, L., Paniello, R. C., … Tirosh, I. (2023). Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma. Nature Genetics, 55(4), 640–650. https://doi.org/10.1038/s41588-023-01357-3

Pan, Y., Han, H., Hu, H., Wang, H., Song, Y., Hao, Y., Tong, X., Patel, A. S., Misirlioglu, S., Tang, S., Huang, H.-Y., Geng, K., Chen, T., Karatza, A., Sherman, F., Labbe, K. E., Yang, F., Chafitz, A., Peng, C., … Wong, K.-K. (2023). KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell, 41(1), 88-105.e8. https://doi.org/10.1016/j.ccell.2022.11.015

Savari, O., Febres‐Aldana, C., Chang, J. C., Fanaroff, R. E., Ventura, K., Bodd, F., Paik, P., Vundavalli, M., Saqi, A., Askin, F. B., Travis, W. D., & Rekhtman, N. (2022). Non‐small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours. Histopathology, 82(2), 242–253. Portico. https://doi.org/10.1111/his.14801

Flashner, S., Martin, C., Matsuura, N., Shimonosono, M., Tomita, Y., Morimoto, M., Okolo, O., Yu, V. X., Parikh, A. S., Klein-Szanto, A. J. P., Yan, K., Gabre, J. T., Lu, C., Momen-Heravi, F., Rustgi, A. K., & Nakagawa, H. (2022). Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids. Journal of Visualized Experiments, 190. https://doi.org/10.3791/64676

Li, D., Thomas, C., Shrivastava, N., Gersten, A., Gadsden, N., Schlecht, N., Kawachi, N., Schiff, B. A., Smith, R. V., Rosenblatt, G., Augustine, S., Gavathiotis, E., Burk, R., Prystowsky, M. B., Guha, C., Mehta, V., & Ow, T. J. (2023). Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28388

Bercow, A. S., Rauh-Hain, J. A., Melamed, A., Mazina, V., Growdon, W. B., del Carmen, M. G., Goodman, A., Bouberhan, S., Bregar, A., Eisenhauer, E. L., Molina, G., & Minami, C. (2022). Guideline-Discordant Care in Early-Stage Vulvar Cancer. Obstetrics & Gynecology, 140(6), 1031–1041. https://doi.org/10.1097/aog.0000000000004992

Kao, D. D., Ferrandino, R. M., Bauml, J. M., Marshall, D. C., Bakst, R., Roof, S., Park, Y.-H. A., & Sigel, K. M. (2022). Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck. Oral Oncology, 135, 106216. https://doi.org/10.1016/j.oraloncology.2022.106216

Galeano Niño, J. L., Wu, H., LaCourse, K. D., Kempchinsky, A. G., Baryiames, A., Barber, B., Futran, N., Houlton, J., Sather, C., Sicinska, E., Taylor, A., Minot, S. S., Johnston, C. D., & Bullman, S. (2022). Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature, 611(7937), 810–817. https://doi.org/10.1038/s41586-022-05435-0

Li, Y., Goldberg, E. M., Chen, X., Xu, X., McGuire, J. T., Leuzzi, G., Karagiannis, D., Tate, T., Farhangdoost, N., Horth, C., Dai, E., Li, Z., Zhang, Z., Izar, B., Que, J., Ciccia, A., Majewski, J., Yoon, A. J., Ailles, L., … Lu, C. (2022). Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas. Molecular Cell, 82(20), 3901-3918.e7. https://doi.org/10.1016/j.molcel.2022.09.007

Farrokhian, N., Holcomb, A. J., Dimon, E., Karadaghy, O., Ward, C., Whiteford, E., Tolan, C., Hanly, E. K., Buchakjian, M. R., Harding, B., Dooley, L., Shinn, J., Wood, C. B., Rohde, S., Khaja, S., Parikh, A., Bulbul, M. G., Penn, J., Goodwin, S., & Bur, A. M. (2022). Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery, 148(10), 947. https://doi.org/10.1001/jamaoto.2022.2312

Bailey, S., Wang, Q., Kong, C. Y., Stone, K., Veluswamy, R., Bates, S. E., Smith, C. B., Wisnivesky, J. P., & Sigel, K. (2022). Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities. Current Problems in Cancer, 46(4), 100867. https://doi.org/10.1016/j.currproblcancer.2022.100867

Henick, B. S., Villarroel-Espindola, F., Datar, I., Sanmamed, M. F., Yu, J., Desai, S., Li, A., Aguirre-Ducler, A., Syrigos, K., Rimm, D. L., Chen, L., Herbst, R. S., & Schalper, K. A. (2022). Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer, 10(7), e005025. https://doi.org/10.1136/jitc-2022-005025

Eng, C., Ciombor, K. K., Cho, M., Dorth, J. A., Rajdev, L. N., Horowitz, D. P., Gollub, M. J., Jácome, A. A., Lockney, N. A., Muldoon, R. L., Washington, M. K., O’Brian, B. A., Benny, A., Lebeck Lee, C. M., Benson, A. B., Goodman, K. A., & Morris, V. K. (2022). Anal Cancer: Emerging Standards in a Rare Disease. Journal of Clinical Oncology, 40(24), 2774–2788. https://doi.org/10.1200/jco.21.02566

Tchelebi, L. T., Eng, C., Messick, C. A., Hong, T. S., Ludmir, E. B., Kachnic, L. A., & Zaorsky, N. G. (2021). Current treatment and future directions in the management of anal cancer. CA: A Cancer Journal for Clinicians, 72(2), 183–195. Portico. https://doi.org/10.3322/caac.21712

Kachnic, L. A., Winter, K. A., Myerson, R. J., Goodyear, M. D., Abitbol, A. A., Streeter, O. E., Augspurger, M. E., Schefter, T. E., Katz, A. W., Fisher, B. J., Henke, L. E., Narayan, S., & Crane, C. H. (2022). Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. International Journal of Radiation Oncology*Biology*Physics, 112(1), 146–157. https://doi.org/10.1016/j.ijrobp.2021.08.008

Liu, Y., Wu, Z., Zhou, J., Ramadurai, D. K. A., Mortenson, K. L., Aguilera-Jimenez, E., Yan, Y., Yang, X., Taylor, A. M., Varley, K. E., Gertz, J., Choi, P. S., Cherniack, A. D., Chen, X., Bass, A. J., Bailey, S. D., & Zhang, X. (2021). A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27055-4

Shimonosono, M., Tanaka, K., Flashner, S., Takada, S., Matsuura, N., Tomita, Y., Sachdeva, U. M., Noguchi, E., Sangwan, V., Ferri, L., Momen-Heravi, F., Yoon, A. J., Klein-Szanto, A. J., Diehl, J. A., & Nakagawa, H. (2021). Alcohol Metabolism Enriches Squamous Cell Carcinoma Cancer Stem Cells That Survive Oxidative Stress via Autophagy. Biomolecules, 11(10), 1479. https://doi.org/10.3390/biom11101479

Massey, P. R., Schmults, C. D., Li, S. J., Arron, S. T., Asgari, M. M., Bouwes Bavinck, J. N., Billingsley, E., Blalock, T. W., Blasdale, K., Carroll, B. T., Carucci, J. A., Chong, A. H., Christensen, S. R., Chung, C. L., DeSimone, J. A., Ducroux, E., Escutia-Muñoz, B., Ferrándiz-Pulido, C., Fox, M. C., … Jambusaria-Pahlajani, A. (2021). Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients. JAMA Dermatology, 157(10), 1219. https://doi.org/10.1001/jamadermatol.2021.3180

Leighl, N. B., Redman, M. W., Rizvi, N., Hirsch, F. R., Mack, P. C., Schwartz, L. H., Wade, J. L., Irvin, W. J., Reddy, S. C., Crawford, J., Bradley, J. D., Stinchcombe, T. E., Ramalingam, S. S., Miao, J., Minichiello, K., Herbst, R. S., Papadimitrakopoulou, V. A., Kelly, K., & Gandara, D. R. (2021). Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760). Journal for ImmunoTherapy of Cancer, 9(8), e002973. https://doi.org/10.1136/jitc-2021-002973